Oligonucleotide Synthesis Market is projected to reach $10.17 billion by 2032, growing at a CAGR of 12.55%

𝐓𝐡𝐞 𝐨𝐥𝐢𝐠𝐨𝐧𝐮𝐜𝐥𝐞𝐨𝐭𝐢𝐝𝐞 𝐬𝐲𝐧𝐭𝐡𝐞𝐬𝐢𝐬 𝐦𝐚𝐫𝐤𝐞𝐭 𝐬𝐢𝐳𝐞 𝐰𝐚𝐬 𝐯𝐚𝐥𝐮𝐞𝐝 𝐚𝐭 𝐔𝐒𝐃 𝟑.𝟓𝟓 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 𝟐𝟎𝟐𝟑. 𝐓𝐡𝐞 𝐦𝐚𝐫𝐤𝐞𝐭 𝐨𝐮𝐭𝐥𝐨𝐨𝐤 𝐢𝐬 𝐚𝐧𝐭𝐢𝐜𝐢𝐩𝐚𝐭𝐞𝐝 𝐭𝐨 𝐠𝐫𝐨𝐰 𝐟𝐫𝐨𝐦 𝐔𝐒𝐃 𝟑.𝟗𝟓 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 𝟐𝟎𝟐𝟒 𝐭𝐨 𝐔𝐒𝐃 𝟏𝟎.𝟏𝟕 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 𝟐𝟎𝟑𝟐, 𝐞𝐱𝐡𝐢𝐛𝐢𝐭𝐢𝐧𝐠 𝐚 𝐂𝐀𝐆𝐑 𝐨𝐟 𝟏𝟐.𝟓𝟓% 𝐝𝐮𝐫𝐢𝐧𝐠 𝐭𝐡𝐞 𝐟𝐨𝐫𝐞𝐜𝐚𝐬𝐭 𝐩𝐞𝐫𝐢𝐨𝐝. 𝐒𝐨𝐦𝐞 𝐨𝐟 𝐭𝐡𝐞 𝐫𝐞𝐚𝐬𝐨𝐧𝐬 𝐟𝐨𝐫 𝐭𝐡𝐢𝐬 𝐦𝐚𝐫𝐤𝐞𝐭 𝐞𝐱𝐩𝐚𝐧𝐬𝐢𝐨𝐧 𝐚𝐫𝐞:

• Various governments are significantly funding research and development in areas such as pharmaceuticals and biotechnology, which is driving market expansion.
• The market for oligonucleotide synthesis is undergoing substantial growth fueled by increased research and development efforts by industry players.
• The growth of manufacturing plants by major companies to meet increasing customer needs is contributing to market growth.
• Rising use of synthesized oligonucleotides in molecular diagnostics and clinical uses is expected to boost market demand.

𝐌𝐚𝐫𝐤𝐞𝐭 𝐈𝐧𝐭𝐫𝐨𝐝𝐮𝐜𝐭𝐢𝐨𝐧:
An oligonucleotide is a short, synthetic strand of DNA or RNA, typically consisting of less than 20 nucleotides, which can be single or double-stranded and is used in various molecular biology applications like PCR, DNA sequencing, and gene expression analysis due to its ability to bind to complementary DNA or RNA sequences specifically. Oligonucleotide synthesis is a chemical process where short, single-stranded DNA molecules with specific sequences are created by linking together individual nucleotides in a controlled manner, primarily using a method called phosphoramidite chemistry, which allows for precise sequence design and is widely used in molecular biology research and applications like PCR, gene sequencing, and diagnostics.

𝐆𝐞𝐭 𝐄𝐱𝐜𝐥𝐮𝐬𝐢𝐯𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐚𝐠𝐞𝐬 𝐨𝐟 𝐓𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭:
https://www.polarismarketresearch.com/industry-analysis/oligonucleotide-synthesis-market/request-for-discount-pricing

𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 𝐢𝐧 𝐌𝐚𝐫𝐤𝐞𝐭:
Leading service providers in the market are consistently enhancing their technologies to maintain a competitive edge and to guarantee efficiency, integrity, and safety. Major players in the market are:

• Agilent Technologies
• ATDBio Ltd.
• Bio-Synthesis Inc.
• Biosearch Technologies
• Eurofins Genomics
• GE Healthcare
• Genewiz
• GenScript Corporation
• Integrated DNA Technologies (IDT)
• LGC Biosearch Technologies

𝐎𝐥𝐢𝐠𝐨𝐧𝐮𝐜𝐥𝐞𝐨𝐭𝐢𝐝𝐞 𝐒𝐲𝐧𝐭𝐡𝐞𝐬𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐢𝐠𝐡𝐥𝐢𝐠𝐡𝐭𝐬
• In 2023, the synthesized oligonucleotide products segment is expected to witness highest growth during forecast period owing to increased prevalence of genomic studies

• PCR primers segment is expected to dominate the oligonucleotide synthesis market during forecast period. This is attributed to increase in detecting and measuring gene expression

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐟𝐨𝐫 𝐚 𝐃𝐢𝐬𝐜𝐨𝐮𝐧𝐭 𝐨𝐧 𝐭𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 𝐁𝐞𝐟𝐨𝐫𝐞 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞:
https://www.polarismarketresearch.com/industry-analysis/oligonucleotide-synthesis-market/request-for-discount-pricing

𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐥 𝐎𝐯𝐞𝐫𝐯𝐢𝐞𝐰:
• The oligonucleotide synthesis market is segmented based on product, application, and region.
• Based on the product, the market is segmented into services, reagents, equipment, and synthesized oligonucleotides.
• The segment for synthesized oligonucleotide products is expected to experience the fastest growth over the forecast period. This increase is linked to the increased occurrence of genomic research, such as gene expression evaluation and genetic testing.
• The oligonucleotide synthesis market based on application is segmented as fluorescence in situ hybridization (FISH), antisense oligonucleotides, sequencing, DNA microarrays, PCR primers, PCR assays and panels, and others.
• PCR primers segment dominated the market by holding the largest market share in 2023. This is attributed to them being used extensively in the PCR process.

Oligonucleotide Synthesis, Product Outlook (Revenue - USD Billion, 2019 - 2032)
• Synthesized Oligonucleotide Products
• Equipment
• Reagents
• Services

Oligonucleotide Synthesis, Application Outlook (Revenue - USD Billion, 2019 - 2032)
• PCR Assays and Panels
• PCR Primers
• DNA Microarrays
• Sequencing
• Antisense Oligonucleotides
• Fluorescence in Situ Hybridization (FISH)
• Others

𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐓𝐡𝐞 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐂𝐨𝐦𝐩𝐫𝐞𝐡𝐞𝐧𝐬𝐢𝐯𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐞𝐫𝐞:
https://www.polarismarketresearch.com/industry-analysis/oligonucleotide-synthesis-market

𝐑𝐞𝐠𝐢𝐨𝐧𝐚𝐥 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬:
Oligonucleotide Synthesis, Regional Outlook (Revenue - USD Billion, 2019 - 2032)
• North America
o U.S.
o Canada

• Europe
o France
o Germany
o UK
o Italy
o Netherlands
o Spain
o Russia
o Rest of Europe

• Asia Pacific
o Japan
o China
o India
o Malaysia
o Indonesia
o South Korea
o Australia
o Rest of APAC

𝐌𝐨𝐫𝐞 𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐋𝐚𝐭𝐞𝐬𝐭 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 𝐛𝐲 𝐏𝐨𝐥𝐚𝐫𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡:
Air Ambulance Services Market
https://www.polarismarketresearch.com/industry-analysis/air-ambulance-services-market

3D Cell Culture Market
https://www.polarismarketresearch.com/industry-analysis/3d-cell-culture-market

Breast Lesion Localization Methods Market
https://www.polarismarketresearch.com/industry-analysis/breast-lesion-localization-methods-market

Geriatric Medicines Market
https://www.polarismarketresearch.com/industry-analysis/geriatric-medicines-market

𝐂𝐨𝐧𝐭𝐚𝐜𝐭:

Likhil G
8 The Green Ste 19824,
Dover, DE 19901,
United States
Phone: +1-929 297-9727
Email: sales@polarismarketresearch.com
Web: https://www.polarismarketresearch.com
Follow Us: LinkedIn | Twitter

𝐀𝐛𝐨𝐮𝐭 𝐏𝐨𝐥𝐚𝐫𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 & 𝐂𝐨𝐧𝐬𝐮𝐥𝐭𝐢𝐧𝐠, 𝐈𝐧𝐜:

Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.

This release was published on openPR.